Fast Track is a process designed to expedite FDA review and get important new drugs to the patient earlier.
Lupus is the feature of a new publication by the largest non-profit alliance committed to making medical research a national priority.
This week, LFA-supported researchers will share results of a study that could help expedite the delivery of new and safer therapies to people with lupus.
30 researchers funded by the LFA are presenting this week at the annual scientific meeting of the American College of Rheumatology. #ACR16 is among the world’s largest gatherings where results of medical research studies in the area of rheumatology are presented for critical peer evaluation.
We're honored to announce the winners of this year's Evelyn V. Hess Award and Mary Betty Stevens Young Investigator Prize.
The LFA has launched a Crowdrise campaign to draw attention to the sacrifices people with lupus are forced to make.
Reports that Toni Braxton was hospitalized for complications from lupus are a reminder that people with lupus experience disease flares that can be triggered by environmental factors like stress or exhaustion.
Pain is cited as the most common reason Americans access the health care system.